ProQR Therapeutics N.V. buy Chardan Capital
Start price
12.12.24
/
50%
€3.10
Target price
12.12.25
€3.81
Performance (%)
-37.48%
End price
13.12.25
€1.94
Summary
This prediction ended on 13.12.25 with a price of €1.94. Massive losses of -37.48% were the result for the BUY prediction by Chardan_Capital. Chardan_Capital has a follow-up prediction for ProQR Therapeutics N.V. where he still thinks ProQR Therapeutics N.V. is a Buy. Chardan_Capital has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| ProQR Therapeutics N.V. | -4.164% | -4.164% | -6.270% |
| iShares Core DAX® | -1,10 % | -6,08 % | 3,20 % |
| iShares Nasdaq 100 | 0,33 % | 2,33 % | 20,24 % |
| iShares Nikkei 225® | -1,08 % | -7,99 % | 27,55 % |
| iShares S&P 500 | -0,06 % | 0,88 % | 14,89 % |
Comments by Chardan_Capital for this prediction
In the thread ProQR Therapeutics N.V. diskutieren
ProQR Therapeutics (NASDAQ: PRQR) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $4.00 price target on the stock.
Ratings data for PRQR provided by MarketBeat
In the thread Trading ProQR Therapeutics N.V.
Die von Chardan_Capital gewählte maximale Laufzeit wurde überschritten
Current prediction by Chardan_Capital for ProQR Therapeutics N.V.
ProQR Therapeutics N.V.
Start price
Target price
Perf. (%)
€1.59
14.03.25
14.03.25
€3.69
14.03.26
14.03.26
-0.25%
13.03.26
13.03.26
Stopped prediction by Chardan_Capital for ProQR Therapeutics N.V.
ProQR Therapeutics N.V.
Start price
Target price
Perf. (%)
€2.05
04.11.25
04.11.25
€3.48
04.11.26
04.11.26
-29.13%
13.03.26
13.03.26
ProQR Therapeutics N.V.
Start price
Target price
Perf. (%)
€1.80
08.08.25
08.08.25
€3.43
08.08.26
08.08.26
-11.57%
13.03.26
13.03.26
ProQR Therapeutics N.V.
Start price
Target price
Perf. (%)
€1.86
10.05.24
10.05.24
€2.32
10.05.25
10.05.25
-20.11%
11.05.25
11.05.25
ProQR Therapeutics N.V.
Start price
Target price
Perf. (%)
€1.27
08.11.23
08.11.23
€1.87
08.11.24
08.11.24
170.93%
09.11.24
09.11.24